NEXUS Biosystems Buys Swiss Firm

Poway-based NEXUS Biosystems, a developer of automated sample management systems for the biopharmaceuticals industry, said Thursday that it has signed an agreement to acquire REMP AG, a Swiss-based firm which provides sample management systems and related products. REMP AG is a subsidiary of Tecan Group. Financial terms of the deal were not disclosed. REMP AG is based in Oderdiessbach, Switzerland. NEXUS said it was supported in the acquisition by its majority investor, private equity firm Telegraph Hill Partners.